SofWave Medical Ltd. (TLV:SOFW)

Market Cap	754.78M
Revenue (ttm)	235.09M
Net Income (ttm)	-17.41M
Shares Out	35.32M
EPS (ttm)	-0.50
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,103
Average Volume	56,738
Open	2,140.00
Previous Close	2,139.00
Day's Range	2,105.00 - 2,169.00
52-Week Range	1,300.00 - 2,222.00
Beta	0.70
RSI	67.91
Earnings Date	May 8, 2025

About SofWave Medical

SofWave Medical Ltd. engages in the development, production, marketing, support, and distribution of ultrasound technology for non-invasive skin rejuvenation and firming treatment in Israel and internationally. It offers aesthetic medical devices to plastic surgeons, dermatologists, and other doctors who perform aesthetic treatments on patient under the Softwave brand name. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2015
• Employees: 126
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: SOFW

Financial Performance

In 2024, SofWave Medical's revenue was $59.65 million, an increase of 18.56% compared to the previous year's $50.32 million. Losses were -$4.55 million, -45.08% less than in 2023.

Financial numbers in USD